Review: taking Maxalt and Xanax together


Summary

Drug interactions are reported among people who take Maxalt and Xanax together. This review analyzes the effectiveness and drug interactions between Maxalt and Xanax. It is created by eHealthMe based on reports of 415 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Maxalt and Xanax >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Maxalt

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. (latest outcomes from Maxalt 5,052 users)

Xanax

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. (latest outcomes from Xanax 67,594 users)

On Aug, 28, 2016

415 people who take Maxalt, Xanax are studied.


Number of reports submitted per year:

Maxalt and Xanax drug interactions.

Drug effectiveness over time:

Maxalt:
  • < 1 month: 75.0% - (3 of 4 people)
  • 1 - 6 months: 57.0% - (4 of 7 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 57.0% - (4 of 7 people)
  • 5 - 10 years: 100.0% - (6 of 6 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Xanax:
  • < 1 month: 40.0% - (2 of 5 people)
  • 1 - 6 months: 42.0% - (3 of 7 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 83.0% - (5 of 6 people)
  • 2 - 5 years: 100.0% - (4 of 4 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 100.0% - (3 of 3 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Maxalt:
  • female: 68.0% - (20 of 29 people)
  • male: 0.0% - (0 of 3 people)
Xanax:
  • female: 68.0% - (20 of 29 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Maxalt:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 57.0% - (4 of 7 people)
  • 30-39: 40.0% - (4 of 10 people)
  • 40-49: 72.0% - (8 of 11 people)
  • 50-59: 100.0% - (3 of 3 people)
  • 60+: 0.0% - (0 of 0 people)
Xanax:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 57.0% - (4 of 7 people)
  • 30-39: 70.0% - (7 of 10 people)
  • 40-49: 63.0% - (7 of 11 people)
  • 50-59: 100.0% - (3 of 3 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anaemia
  • complications of transplanted kidney
  • cytomegalovirus viraemia
  • hyperkalaemia
  • kidney transplant rejection
  • lymphocyte count decreased
  • parvovirus infection
  • pyelonephritis acute
  • renal tubular necrosis
  • thrombocytopenia
1 - 6 months:
  • anxiety
  • pulmonary embolism
  • arterial thrombosis
  • cyanosis
  • depression
  • drug hypersensitivity
  • dyspnoea
  • emotional distress
  • fear of death
  • pain
6 - 12 months:
  • abdominal discomfort
  • anhedonia
  • anxiety
  • cholecystitis chronic
  • deformity
  • gallbladder disorder
  • injury
  • pain
  • hallucinations, mixed
1 - 2 years:
  • abdominal discomfort
  • anhedonia
  • anxiety
  • blood pressure diastolic increased
  • blood pressure increased
  • cholecystitis chronic
  • cognitive disorder
  • deformity
  • gallbladder disorder
  • injury
2 - 5 years:
  • blood pressure diastolic increased
  • blood pressure increased
  • cholecystitis chronic
  • cognitive disorder
  • gallbladder disorder
  • migraine
  • neurotransmitter level altered
  • pain
  • pain - head
  • pancreatitis
5 - 10 years:
  • headache
  • increased tendency to bruise
  • insomnia
  • tremor
  • itching
  • neck pain
  • abnormal weight gain
  • appetite increased
  • bone pain
  • decreased activity
10+ years:
  • deep vein thrombosis
  • pulmonary embolism
  • abnormal weight gain
  • appetite increased
  • bone pain
  • decreased activity
  • decreased interest
  • exercise tolerance decreased
  • fall
  • heat intolerance
not specified:
  • nausea
  • anxiety
  • pain
  • arthralgia
  • vomiting
  • asthenia
  • headache
  • neuropathy peripheral
  • diarrhoea
  • migraine

Most common drug interactions by gender *:

female:
  • nausea
  • anxiety
  • pain
  • headache
  • arthralgia
  • asthenia
  • vomiting
  • depression
  • neuropathy peripheral
  • migraine
male:
  • fall
  • pain
  • muscle spasms
  • insomnia
  • chronic obstructive pulmonary disease
  • hypoaesthesia
  • memory impairment
  • pain in extremity
  • paraesthesia
  • emotional distress

Most common drug interactions by age *:

2-9:
  • abdominal pain upper
  • ankle fracture
  • arthropathy
  • bipolar disorder
  • bipolar i disorder
  • bronchitis chronic
  • cardiac arrest
  • cardiac disorder
  • cardiomegaly
  • chronic obstructive pulmonary disease
10-19:
  • cholecystitis chronic
  • gallbladder disorder
  • pain
  • pancreatitis
  • sphincter of oddi dysfunction
20-29:
  • chest pain
  • dyspnoea
  • palpitations
  • anxiety
  • confusional state
  • diarrhoea
  • pulmonary embolism
  • aphasia
  • balance disorder
  • cholelithiasis
30-39:
  • pain
  • anxiety
  • bronchitis
  • dizziness
  • depression
  • migraine
  • sinusitis
  • nausea
  • neuropathy peripheral
  • headache
40-49:
  • anxiety
  • depression
  • fatigue
  • feeling abnormal
  • nausea
  • pain
  • headache
  • asthma
  • insomnia
  • memory impairment
50-59:
  • nausea
  • vomiting
  • anaemia
  • hypoaesthesia
  • asthenia
  • abdominal pain
  • arthralgia
  • diarrhoea
  • intervertebral disc protrusion
  • pain in extremity
60+:
  • weight increased
  • glycosylated haemoglobin increased
  • headache
  • aphagia
  • arthralgia
  • dysphagia
  • gastric hypomotility
  • hiatus hernia
  • rheumatoid arthritis
  • abdominal distension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Maxalt and Xanax?

Can you answer these questions?

More questions for: Maxalt, Xanax

You may be interested in these reviews

More reviews for: Maxalt, Xanax

On eHealthMe, Maxalt (rizatriptan benzoate) is often used to treat migraine. Xanax (alprazolam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.